Alterity Therapeutics (ATHE) Net Cash Flow (2009 - 2020)
Alterity Therapeutics (ATHE) posted quarterly Net Cash Flow of -$6.2 million for Q2 2020, up 36.76% year-over-year from -$4.5 million in Q3 2019, and down 420.59% quarter-over-quarter from $1.9 million in Q4 2019.
Alterity Therapeutics (ATHE) Net Cash Flow (2009 - 2020) Analysis & Trends
Alterity Therapeutics' Net Cash Flow history runs 9 years deep, the most recent figure standing at -$6.2 million for Q2 2020.
- In Q2 2020, Net Cash Flow rose 36.76% year-over-year to -$6.2 million; the TTM figure through Dec 2021 stood at -$6.2 million (up 55.94% YoY), while the FY2025 annual figure was $13.3 million, up 692.99% from the prior year.
- Net Cash Flow for Q2 2020 stood at -$6.2 million, down from $1.9 million in the prior quarter.
- The five-year high for Net Cash Flow was $1.9 million in Q4 2019, with the low at -$9.8 million in Q2 2019.
- The 5-year median for Net Cash Flow is -$4.4 million (2017), against an average of -$3.4 million.
- Peak annual rise in Net Cash Flow reached 137.95% in 2019, while the deepest fall reached 20575.33% in 2019.
- Alterity Therapeutics' Net Cash Flow stood at -$598231.8 in 2016, then tumbled by 56.04% to -$933486.7 in 2017, then slumped by 444.27% to -$5.1 million in 2018, then jumped by 137.95% to $1.9 million in 2019, then sank by 420.59% to -$6.2 million in 2020.
- Business Quant data shows ATHE's Net Cash Flow at -$6.2 million in Q2 2020, $1.9 million in Q4 2019, and -$9.8 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -6.18 Mn |
| Jun 30, 2020 | -6.18 Mn |
| Dec 31, 2019 | 1.93 Mn |
| Dec 31, 2019 | 1.93 Mn |
| Jun 30, 2019 | -9.77 Mn |
| Jun 30, 2019 | -9.77 Mn |
| Dec 31, 2018 | -5.08 Mn |
| Dec 31, 2018 | -5.08 Mn |
| Jun 30, 2018 | -47,278.38 |
| Jun 30, 2018 | -47,278.38 |
| Dec 31, 2017 | -933,486.69 |
| Dec 31, 2017 | -933,486.69 |
| Jun 30, 2017 | -4.41 Mn |
| Jun 30, 2017 | -4.41 Mn |
| Dec 31, 2016 | -598,231.82 |
| Dec 31, 2016 | -598,231.82 |
| Jun 30, 2016 | -5.54 Mn |
| Jun 30, 2016 | -5.54 Mn |
| Jun 30, 2012 | -6,916.69 Bn |
| Jun 30, 2012 | -6,916.69 Bn |